Corcept Therapeutics Inc

CORTNASDAQ · US

Holders

REDUCEDT+2
Mahoney David L
Corcept Therapeutics Inc · NASDAQ
−91,167 sh · $10.8M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahoney David L
Corcept Therapeutics Inc · NASDAQ
−400 sh · $47.9K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahoney David L
Corcept Therapeutics Inc · NASDAQ
−4,984 sh · $585.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Mahoney David L
Corcept Therapeutics Inc · NASDAQ
−7,055 sh · $838.7K
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Corcept Therapeutics Inc · NASDAQ
5,261,628 sh · $457.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Corcept Therapeutics Inc · NASDAQ
945,884 sh · $38.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Corcept Therapeutics Inc · NASDAQ
5,682,783 sh · $229.1M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
Corcept Therapeutics Inc · NASDAQ
38,422 sh · $1.5M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Corcept Therapeutics Inc · NASDAQ
5,758,528 sh · $200.4M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Corcept Therapeutics Inc · NASDAQ
28,363 sh · $2.4M
Filed 30 Sept 2025SEC 13Fview source